share_log

Avalo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Caissa Capital Management Ltd.(0%),Cambyz Golestaneh(0%)

Avalo Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Caissa Capital Management Ltd.(0%),Cambyz Golestaneh(0%)

SEC announcement ·  2023/06/29 08:22
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息